Canal Insurance CO Purchases Shares of 120,000 ARK Genomic Revolution ETF $ARKG

Canal Insurance CO purchased a new stake in ARK Genomic Revolution ETF (BATS:ARKG) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 120,000 shares of the company’s stock, valued at approximately $3,476,000.

Other hedge funds also recently made changes to their positions in the company. Sunbelt Securities Inc. boosted its holdings in shares of ARK Genomic Revolution ETF by 734.3% in the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock valued at $31,000 after purchasing an additional 984 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new position in shares of ARK Genomic Revolution ETF in the 2nd quarter valued at $38,000. Advisory Services Network LLC acquired a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at $58,000. FWL Investment Management LLC boosted its holdings in shares of ARK Genomic Revolution ETF by 17.1% in the 3rd quarter. FWL Investment Management LLC now owns 3,239 shares of the company’s stock valued at $90,000 after purchasing an additional 474 shares during the last quarter. Finally, Optiver Holding B.V. acquired a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at $126,000.

ARK Genomic Revolution ETF Trading Down 2.2%

Shares of ARKG opened at $30.38 on Friday. The company’s fifty day moving average is $28.29 and its two-hundred day moving average is $29.47. ARK Genomic Revolution ETF has a fifty-two week low of $20.26 and a fifty-two week high of $34.39.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.